0
0
12/11/23 at 8:37pm
Organization
Ftc.gov
49 words
0
Comments
The Federal Trade Commission is seeking to block Sanofi’s proposed acquisition of an exclusive license to Maze Therapeutics Inc.’s therapy in development for treatment of Pompe disease.
You are the first to view
https://www.ftc.gov/news-events/news/press-releases/2023/12/ftc-seeks-block-sanofis-acquisition-rare-disease-drug-threatens-sanofis-monopoly
Create an account
or login to join the discussion